Abstract:Background: Intestinal permeability is increased in many gut disorders, but is difficult to measure in humans.Currently, intestinal permeability is assessed in people using surrogate measures of barrier function, such as concentrations of circulating bacterial lipopolysaccharide (LPS), indicators of exposure to gut bacteria such as antibodies to LPS, LPS binding protein, and α-1-acid glycoprotein, and fecal α-1-antitrypsin.Many studies have used dual sugar absorption tests to probe gut permeability, which measure the ratios in urine of a disaccharide (generally lactulose) to a monosaccharide (generally rhamnose or lactulose) following oral ingestion.If barrier function is impaired, the ratios of the heavier to the lighter sugar are elevated.This theoretically sound test is compromised by specimen handling and assay challenges, and reliance on an arbitrarily time point for assessment.Pyrazine-derived fluorophores MB-402 (MW=422, peak excitation l=500 nm, peak emission=620 nm) and MB-301 (MW=198, peak excitation l=405 nm, peak emission=540 nm) detect small bowel injury in rats challenged with indomethacin (Sci Rep 2017;7:10888).Following oral ingestion, these fluorophores can be measured through the skin using transcutaneous sensor technology, as is now employed in clinical studies to measure glomerular filtration rates, and provide more robust tracings and dynamic range in a dose response model.Methods.We tested in our rat model MB-404 (MW = 492, peak excitation=500 nm, peak emission=620 nm).MB-404 contains eight hydroxyl groups (vs.four in MB-402), retains MB-402's acid-resistance, and is soluble in water.We gavaged MB-404 ( 92mg/kg) in combination with MB-301 (16 mg/kg).Results.Urinary MB-404:MB-301 ratios recapitulate (Fig 1) MB-402:MB-301 urine ratios.Simultaneous continuous transcutaneous monitoring detects each fluorophore in the extracellular space of the rats over eight hours resemble the cumulative urinary clearance of the fluorophores, demonstrating the feasibility of measuring tracer uptake from the gut without taking possession of urine or other fluids.Transcutaneous monitoring and urinary concentrations also enabled us to test if the ratios of MB-404 and MB-301 were superior to the uptake and clearances of individual tracers.The transcutaneous assessment measurement of extracellular MB-404 by itself (Fig 2) discriminated injured vs. control rats better than did ratios of the two fluorophores.Conclusion.MB-404's greater solubility offers advantages over MB-402 in dual fluorophore tests of gut permeability.Most importantly, MB-404 uptake from the gut following oral ingestion offers greater sensitivity as a single tracer than when used in tandem with MB-301.The ability to test gut permeability with a single tracer will facilitate upcoming trials of fluorophore tracers in people with intestinal enteropathy.

In vivo assessing colitis severity by topical administration of fluorescent probe against neutrophils

Dual-Locked Chemiluminescent Probe Enables Precise Imaging and Timely Diagnosis of Colitis Via Chymotrypsin/Vanin-1 Cascade Activation

Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination Between Chronic and Acute Ulcerative Colitis.

Near-infrared Fluorescence Probe with a Large Stokes Shift for Visualizing Hydrogen Peroxide in Ulcerative Colitis Mice

A ROS-responsive fluorescent probe detecting experimental colitis by functional polymeric nanoparticles

Neutrophil Elastase-Activated Carbon Dots for Non-Invasive Early Diagnosis of Inflammatory Bowel Disease by Near-Infrared-ii Fluorescence Imaging

A Ratiometric Fluorescent Probe Activated by Neutrophil Elastase As a Novel Strategy for Early Tumor Diagnosis

Activatable Fluorogenic Probe for Accurate Imaging of Ulcerative Colitis Hypoxia in Vivo

Fluorescence endoscopic detection of murine colitis-associated colon cancer by topically applied enzymatically rapid-activatable probe

Application of a chemical probe to detect neutrophil elastase activation during inflammatory bowel disease

An intestinal-targeting near-infrared probe for imaging nitroreductase in inflammatory bowel disease

In Vivo Imaging of Reactive Oxygen and Nitrogen Species in Murine Colitis.

A Chemiluminescent Reporter Assisted by In-Situ Neutrophils for Imaging O2- at Inflammatory Sites.

Detection of Colonic Neoplasia in Vivo Using Near-Infrared-labeled Peptide Targeting Cmet.

A highly sensitive NIR fluorescence probe for hypoxia imaging in cells and ulcerative colitis

Non-invasive Diagnosis of Bacterial and Non-Bacterial Inflammations Using a Dual-Enzyme-responsive Fluorescent Indicator

An AIEgen-based oral-administration nanosystem for detection and therapy of ulcerative colitis via 3D-MSOT/NIR-II fluorescent imaging and inhibiting NLRP3 inflammasome

Su2051 – Intracolic Molecular Ultrasound Imaging for Non-Invasive and Quantitative Assessment of Tumor Necrosis Factor-α Expression in Inflammatory Bowel Disease

In Vivo Staging of Colitis, Adenoma and Carcinoma in CRC Progression by Combination of H4R/DRD4-targeted Fluorescent Probes

Activity-based Ratiometric Fluorescent Small-Molecule Probe for Endogenously Monitoring Neutrophil Elastase in Living Cells.

Carboxylesterase 2-Based Fluorescent Probe with Large Stokes Shift for Differentiating Colitis from Bowel Cancer